Cm Management, LLC Edesa Biotech, Inc. Transaction History

Cm Management, LLC

  • $108 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
BUY
$0.63 - $0.99 $26,839 - $42,175
42,602 Added 11.36%
417,602 $263,000
Q2 2023

Aug 04, 2023
BUY
$0.77 - $1.16 $38,500 - $57,999
50,000 Added 15.38%
375,000 $304,000
Q1 2023

May 08, 2023
BUY
$0.91 - $2.63 $11,126 - $32,157
12,227 Added 3.91%
325,000 $296,000
Q4 2022

Feb 09, 2023
BUY
$0.8 - $8.05 $50,218 - $505,322
62,773 Added 25.11%
312,773 $676,000
Q3 2022

Nov 04, 2022
BUY
$1.39 - $9.94 $347,500 - $2.49 Million
250,000 New
250,000 $230,000

About Edesa Biotech, Inc.

EDSA Quotes by TradingView
  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $38.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Cm Management, LLC Portfolio

Follow Cm Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email